Ian Lipkin, one of the experts interviewed for this episode of Frontline, is the director of the Center for Infection and Immunity at the Mailman School. Dr. Lipkin's comments begin at 21:45.
The 2014 expansion of Medicaid in New York state was linked to a significant decrease in severe complications during labor and delivery among low-income women, a new Columbia study has found.
Restoring an enzyme that maintains the way chromosomes are packed inside cells may lead to new therapies for some blood cancers, according to a new study by Columbia researchers.
At Columbia's Vagelos College of Physicians and Surgeons, administrators focus on ensuring that future doctors of color “are provided with mentors,” said Dr. Anne Armstrong-Coben, dean of admissions.
The HPV vaccine has great potential to reduce the rate of cervical cancer in Africa, where Columbia researchers are trying to increase vaccination rates with texts.
Dr. David Ho, an infectious disease expert at Columbia University, and his colleagues also tested the monoclonal antibody therapies against the coronavirus variant discovered in Britain.
Prioritizing older New Yorkers for COVID vaccines and delaying second doses could reduce hospitalizations and deaths, according to new modeling projections from Mailman epidemiologists.
Organizations have begun helping doctors and nurses with mental health issues. Columbia University, for example, created CopeColumbia for employees of Columbia University Irving Medical Center.
